Skip to content

Clinical trials

Phase 2 Diabetes Mellitus, Type 2 trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 2 Phase: Phase 2 Country / region: Canada Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20042
20055
20065
200710
20087
20096
20106
201110
20125
20134
20142
20155
20163
20176
20183
20194
20202
20212
20222
20235
20244
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87
Unknown status7
Terminated6
Recruiting3
Withdrawn2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S8
Pfizer8
AstraZeneca7
Boehringer Ingelheim6
University Health Network, Toronto6
Eli Lilly and Company5
University of Toronto5
Hoffmann-La Roche4
Novartis Pharmaceuticals4
Bristol-Myers Squibb3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 2106
Diabetes Mellitus14
Obesity13
Overweight8
Insulin Resistance7
Renal Insufficiency, Chronic6
Metabolic Syndrome5
Diabetic Nephropathies4
Glucose Intolerance4
Non-alcoholic Fatty Liver Disease4

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.